LGF
AZN icon

LGT Group Foundation’s AstraZeneca AZN Stock Holding History

LGT Group Foundation’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370M Buy
1,980,315
+90,194
+5% +$17M 4.19% 6
2026
Q1 		$367M Buy
1,890,121
+1,871,583
+10,096% +$361M 4.48% 6
2025
Q4 		$3.43M Buy
18,538
+17,222
+1,309% +$3.02M 0.04% 147
2025
Q3 		$222K Buy
+1,316
New +$199K ﹤0.01% 271
2025
Q1 		– Sell
-1,777
Closed -$233K – 290
2024
Q4 		$233K Buy
+1,777
New +$249K ﹤0.01% 256

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

LGT Group Foundation's AZN Position: Q2 2026 in Review

LGT Group Foundation increased its AstraZeneca (AZN) stake by 4.8% in Q2 2026, buying an estimated $17M and bringing the position to 1,980,315 shares worth $370M. The position accounts for 4.19% of the portfolio, ranked #6.

LGT Group Foundation first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. 957 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • LGT Group Foundation held 1,980,315 shares of AstraZeneca worth $370M as of Q2 2026.
  • LGT Group Foundation bought 90,194 AstraZeneca shares in Q2 2026, an estimated $17M.
  • AstraZeneca made up 4.19% of LGT Group Foundation's portfolio in Q2 2026, its #6 holding.
  • LGT Group Foundation first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
  • 957 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.